What's new

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised

Apr 24, 2025 - 14:03
 0
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

Who is Already Joining The Skift Data + AI Summit This June

Next Article

Kering confirms dividend and board appointments at AGM amid Gucci's continued slump

Related Posts

Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Presentation - Optimizing the dosage of human prescript...

Mar 11, 2025  0

Opinions and letters of support on the qualification of novel methodologies for medicine development

Opinions and letters of support on the qualification of...

Mar 20, 2025  0